Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Gabriel Osorio-Mazilli

Hims & Hers Stock: Buy the Dip or Wait It Out?

One of the most exciting growth stories in the market is that of Hims & Hers Health Inc. (NYSE: HIMS). This company has combined the growth and efficiency aspects of the technology sector with the safety and stability of the medical sector. With this mixture in the business model, investors have the best of both worlds, allowing them to move forward with further upside potential.

[content-module:CompanyOverview|NYSE:HIMS]

However, some concerns are being raised about the stock, given that management has made a new strategic decision that does not sit well with the broader market as of June 2025. Toward the end of May 2025, Hims & Hers stock rose to flirt with its 52-week high prices once again, yet failed to make any further significant breakthroughs after the news was announced.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.